Glucagon receptor antagonists, preparation and therapeutic uses

Details for Australian Patent Application No. 2006342137 (hide)

Owner Eli Lilly and Company

Inventors Conner, Scott Eugene; Li, Jianke; Hipskind, Philip Arthur; Zhu, Guoxin

Agent Spruson & Ferguson

Pub. Number AU-B-2006342137

PCT Pub. Number WO2007/120270

Priority 60/738,723 22.11.05 US

Filing date 16 November 2006

Wipo publication date 25 October 2007

Acceptance publication date 16 February 2012

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/120270 Priority application(s): WO2007/120270

16 February 2012 Application Accepted

  Published as AU-B-2006342137

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006342140-Frame for heavy-duty vehicles

2006342119-Soluble human M-CSF receptor and uses thereof